Active Ingredient(s): Tafenoquine
FDA Approved: * July 20, 2018
Category: Malaria

Tafenoquine, sold under the brand name Krintafel among others, is a medication used to prevent and to treat malaria.[3] With respect to acute malaria, it is used together with other medications to prevent relapse by Plasmodium vivax.[3] It may be used to prevent all types of malaria.[3] It is taken by mouth.[4] Common side effects include vomiting, headache, and dizziness.[4] Other side effects may include methemo... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Krintafel 150 mg Oral Tablet, Film Coated
NDC: 0173-0889
Glaxosmithkline LLC

Related Brands

Drugs with the same active ingredients